Bright Minds Biosciences (DRUG) Current Leases (2022 - 2026)
Bright Minds Biosciences (DRUG) reported Current Leases of $59889.7 for Q1 2026, up 10.53% on a YoY basis from $54185.3 in Q1 2025, and down 5.26% quarter-over-quarter from $63215.5 in Q4 2025.
Bright Minds Biosciences (DRUG) Current Leases (2022 - 2026) Analysis & Trends
Bright Minds Biosciences has reported Current Leases for 5 years, with the latest figure at $59889.7 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 10.53% year-over-year to $59889.7; the trailing twelve-month figure through Mar 2026 stood at $59889.7 (up 10.53% YoY), and the FY2025 full-year result was $61421.0, up 5.55% from the prior year.
- Current Leases for Q1 2026 stood at $59889.7, down from $63215.5 in the prior quarter.
- The five-year high for Current Leases was $63215.5 in Q4 2025, with the low at $10247.7 in Q2 2024.
- Historically, Current Leases has averaged $50130.1 across 5 years, with a median of $54433.5 in 2023.
- Annual changes were most pronounced in 2024 — Current Leases tumbled 82.21% — and 2025, when it jumped 450.65%.
- Bright Minds Biosciences' Current Leases stood at $51505.8 in 2022, then decreased by 22.19% to $40078.5 in 2023, then advanced by 29.79% to $52017.2 in 2024, then advanced by 21.53% to $63215.5 in 2025, then decreased by 5.26% to $59889.7 in 2026.
- The last three Current Leases figures came in at $59889.7 (Q1 2026), $63215.5 (Q4 2025), and $61421.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Bright Minds Biosciences | 16.28 Bn | 16.22 Bn | - | 59,889.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59,889.66 |
| Dec 31, 2025 | 63,215.46 |
| Sep 30, 2025 | 61,421.00 |
| Jun 30, 2025 | 56,429.26 |
| Mar 31, 2025 | 54,185.26 |
| Dec 31, 2024 | 52,017.18 |
| Sep 30, 2024 | 58,192.71 |
| Jun 30, 2024 | 10,247.67 |
| Mar 31, 2024 | 25,775.08 |
| Dec 31, 2023 | 40,078.46 |
| Sep 30, 2023 | 54,862.44 |
| Jun 30, 2023 | 57,614.67 |
| Mar 31, 2023 | 54,433.52 |
| Dec 31, 2022 | 51,505.85 |
| Sep 30, 2022 | 52,083.54 |